Simon N. Pimstone, Director at Xenon Pharmaceuticals Inc. (XENE), sold 283,404 shares at $39.90 ($11.0M) on 2023-05-30, disclosed to the SEC on 2023-06-01.
Open-market sale of $11.0M XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.63 | 18,006 | $696K | 6.3% |
| 2 | $38.63 | 18,006 | $696K | 6.3% |
| 3 | $39.90 | 19,000 | $758K | 6.9% |
| 4 | $38.37 | 6,165 | $237K | 2.2% |
| 5 | $38.37 | 23,144 | $888K | 8.1% |
| 6 | $38.53 | 12,000 |
| $462K |
| 4.2% |
| 7 | $38.69 | 26,856 | $1.0M | 9.5% |
| 8 | $38.69 | 26,856 | $1.0M | 9.5% |
| 9 | $38.81 | 23,670 | $919K | 8.4% |
| 10 | $38.81 | 23,670 | $919K | 8.4% |
| 11 | $38.53 | 1,860 | $72K | 0.7% |
| 12 | $38.53 | 20,745 | $799K | 7.3% |
| 13 | $38.78 | 24,255 | $941K | 8.6% |
| 14 | $38.78 | 24,255 | $941K | 8.6% |
| 15 | $38.97 | 7,458 | $291K | 2.6% |
| 16 | $38.97 | 7,458 | $291K | 2.6% |
| Total | $38.76 avg | 283,404 | $11.0M | 100% |
| Filing → |
| XENE | SELL | 2022-03-08 | $2.2M | — | Filing → |
| XENE | SELL | 2022-03-08 | $77K | — | Filing → |
| XENE | SELL | 2021-11-16 | $1.1M | — | Filing → |